Christopher J. Farady
Papers
1
Total Citations
296
H-Index
1
About
Christopher J. Farady has made pivotal contributions to antiparasitic drug discovery, with a primary focus on cysteine proteases—enzymes critical to the virulence of parasitic diseases. His landmark 2009 study, “Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design” (296 citations), revealed the crystal structures of three major cysteine proteases bound to vinyl sulfone inhibitors, providing a molecular blueprint for designing selective, potent antiparasitic compounds. This work established a structural foundation for targeting papain-family enzymes, which are implicated in diseases such as Chagas disease, leishmaniasis, and malaria. By elucidating key binding interactions and active-site architectures, Farady’s research has guided the development of inhibitors that disrupt parasite survival while sparing host enzymes. His findings remain highly influential in medicinal chemistry and structural biology, cited extensively for their translational potential. Farady’s achievements underscore his role in bridging basic enzymology and therapeutic design, offering a clear path toward novel treatments for neglected tropical diseases.
Research Focus
Key Achievements
Top Papers
- 1Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design296 citations · 2009